Showing 1291-1300 of 3287 results for "".
Coming Soon: New Biopsy Codes
https://practicaldermatology.com/topics/general-topics/coming-soon-new-biopsy-codes/20411/Is your practice prepared for changes to the CPT codes?Skin Cancer Is Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-cancer-emisem-cancer/21341/Of Pandemics and Postponements
https://practicaldermatology.com/topics/practice-management/of-pandemics-and-postponements/23342/Take 5: Strategies for Optimal Outcomes with Dermal Fillers
https://practicaldermatology.com/columns/take-5/take-5-strategies-for-optimal-outcomes-with-dermal-fillers/21949/A dermatologic surgeon's tips for getting the most from dermal fillers and improving patient satisfaction.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20614/Viagra and Aggressive Melanoma: Is There a Link?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/viagra-and-aggressive-melanoma-is-there-a-link/20998/New findings offer insight into the possible effects of the popular prescription on melanoma growth.What 50 Years Ago Means for Today
https://practicaldermatology.com/topics/practice-management/what-50-years-ago-means-for-today/20476/Understanding the SGR: An Explainer
https://practicaldermatology.com/topics/practice-management/understanding-the-sgr-an-explainer/21194/How did the SGR come to be? If it goes away, what will happen to the misplaced focus on physician payments?Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.New Findings Raise Questions About EHRs Going Forward
https://practicaldermatology.com/topics/practice-management/new-findings-raise-questions-about-ehrs-going-forward/22934/A recently published study dampens expectations for the future of EHRs, which may also signal diminished public support.